Cemindo Gemilang Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Cemindo Gemilang Tbk. trades at Rp790 (market cap 13.44T, 22.46M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Cemindo Gemilang Tbk. is far larger — about 43.3× Diagnos Laboratorium Utama Tbk.'s market cap, and Cemindo Gemilang Tbk. is more actively traded (22.46M versus 963.6K). Which is the better fit depends on your goals.
| CMNT | DGNS | |
|---|---|---|
Market Cap | 13.44T | 310.75B |
Volume | 22.46M | 963.6K |
Lot | 224.6K | 9.64K |
Turnover | 17.62B | 217.67M |
Average Price | 784.39 | 225.89 |
Value | 17.62B | 217.67M |
Indicative Equilibrium Price | 790 | 226 |
Indicative Equilibrium Volume | 66 | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cemindo Gemilang Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 9 of Humberg Lie, S.H., S.E., M.Kn, dated July 4, 2011.
Read more on CMNT →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →